Blog
RSS FeedPosted by Michael Wonder on 25 May 2017
CADTH recommends reimbursement of Gilead's Odefsey
25 May 2017 - The CADTH Canadian Drug Expert Committee has recommended that emtricitabine/rilpivirine/tenofovir alafenamide be reimbursed as a complete ...
Posted by Michael Wonder on 18 May 2017
Federal health minister vows to bring down 'unacceptably high' drug costs
16 May 2017 - Health Minister Jane Philpott pledged action Tuesday to bring down "unacceptably high drug costs" as she ...
Posted by Michael Wonder on 17 May 2017
Coalition calls on CADTH to balance scales and fix system
10 May 2017 - Canada's advocacy coalition for people living with depression says CADTH has an opportunity, right now, to ...
Posted by Michael Wonder on 16 May 2017
Canada must (and can) take control of drug prices
16 May 2017 - Canada has the third-highest prescription-drug prices in the world, behind only the United States and Germany. ...
Posted by Michael Wonder on 16 May 2017
Health Minister launches high drug price consultations
16 May 2017 - Canadian drug spending has ballooned by 184% since 2000 as a share of gross domestic product. ...
Posted by Michael Wonder on 10 May 2017
Novartis heart failure treatment Entresto (sacubitril/valsartan) now available to patients in Ontario through the public provincial drug plan
9 May 2017 - Entresto has been shown to reduce the risk of cardiovascular death and hospitalization in heart failure ...
Posted by Michael Wonder on 25 Apr 2017
CADTH symposium examines tough questions about assessing value in health care
23 April 2017 - As health care spending continues to grow, the need to derive maximum value from every health ...
Posted by Michael Wonder on 22 Apr 2017
Alberta promises to offer universal access to the abortion pill
20 April 2017 - Alberta is promising to offer the abortion pill free of charge to all women. ...
Posted by Michael Wonder on 20 Apr 2017
CADTH recommends Kevzara
18 April 2017 - Sarilumab was approved by Health Canada on 12 Jan 2017 for the treatment of adult patients ...
Posted by Michael Wonder on 17 Apr 2017
Expanding CADTH’s drug review processes to include radiopharmaceuticals
17 April 2017 - In collaboration with the participating jurisdictions, CADTH is pleased to announce that it will accept submissions ...
Posted by Michael Wonder on 12 Apr 2017
Patented Medicine Prices Review Board will hear closing arguments in the matter of the price of Soliris
12 April 2017 - Closing arguments in the matter of the price of the patented medicine Soliris will be heard from ...
Posted by Michael Wonder on 11 Apr 2017
Why drugs like these for ‘orphan’ diseases are a booming business with colossal costs for patients
8 April 2017 - Powerful new pharmaceuticals are promising to change the lives of those who suffer from rare diseases. But ...
Posted by Michael Wonder on 06 Apr 2017
CADTH symposium promotes the use of evidence in health care
6 April 2017 - From April 10 to 12, 2016, health care experts from across Canada and around the world ...
Posted by Michael Wonder on 28 Mar 2017
Roche withdraws submission for Avastin
28 March 2017 - Roche was seeking a positive CADTH recommendation for the use of bevacizumab in combination with pemetrexed ...
Posted by Michael Wonder on 27 Mar 2017
CADTH recommends Teva's Cinqair
22 March 2017 - Recommendation states price needs to be reduced by 90%. ...